We're buying more of a tech stock with a bright long-term future

Jim Cramer’s Charitable Trust is buying 280 more Intel shares at roughly $125.38, lifting the position to 780 shares and increasing portfolio weight to 2.5% from 1.6%. The note is bullish on Intel’s CPU demand as agentic AI shifts server-rack mix toward more CPUs and on its foundry opportunity versus TSMC, with additional support from reported customer testing and the Elon Musk Terafab commitment. Intel shares have already rallied $13 since the position was initiated two weeks ago, and Cramer expects further upside.

Analysis

INTC looks less like a single-name momentum trade and more like a crowded-capacity / supply-chain normalization call. The second-order bull case is that AI server architecture is not just expanding accelerator spend; it is also pulling forward more CPU sockets, memory channels, networking, and advanced packaging content per rack, which can expand Intel’s attach rate even if it never wins the GPU war. That matters because CPU demand is sticky and recurring, while the foundry narrative gives the market a longer-dated option on re-rating if execution starts to show credible external volume.

The more interesting implication is negative for the incumbents that depend on a clean TSMC bottleneck. If customers increasingly qualify Intel for packaging and leading-edge fabrication, TSMC’s pricing power may stay intact near term but its strategic optionality weakens as some design wins get dual-sourced. That also raises the bar for pure-play AI beneficiaries: as agentic workloads become more CPU-intensive, a slice of incremental AI capex rotates away from the obvious GPU winners toward infrastructure names that have been underappreciated in the first leg of the cycle.

The main risk is that the market is paying up for a thesis that is still mostly narrative until 2026-2029. Intel’s upside can keep working over the next 1-3 months if AI CPU commentary and foundry qualification headlines continue, but the stock becomes vulnerable if customers delay node commitments, packaging conversion runs into yield issues, or hyperscalers simply absorb the same AI workload with better software efficiency rather than more CPUs. In that case, the move is more re-rating than earnings power, and the multiple can compress quickly if the next data point disappoints.

From a positioning standpoint, this is attractive as a relative-value long, not a blind outright chase. The cleanest expression is long INTC vs short TSM on any strength, betting that incremental foundry displacement and AI CPU mix shift matter more to the marginal stock response than TSM’s already-expected dominance. TSLA is a second-order beneficiary only if the Musk-linked fab story gains credibility, but it is too indirect for high conviction; the better use is optionality around INTC, where a few favorable headlines can extend the move, but execution risk is still meaningful.

Key Decisions for Investors

• Add to INTC on pullbacks over the next 1-3 weeks; use strength to build, not chase, because the trade is likely being driven by forward revisions and headline momentum rather than current fundamentals.
• Express the theme as long INTC / short TSM for 1-3 months; the pair isolates the share-shift and foundry diversification narrative while reducing broad AI beta risk.
• For higher convexity, buy INTC call spreads 3-6 months out; the setup benefits from continued AI/packaging headlines, but defined risk is preferable given long-dated execution uncertainty.
• Trim/avoid fresh TSM longs until there is evidence that dual-sourcing is not just testing but converting to volume; the market may be underestimating how much strategic leverage erodes once customers qualify a credible second source.
• If INTC gaps further on partnership/foundry headlines, take partial profits into that strength and keep a core position only; the upside is real, but the stock remains highly sensitive to credibility gaps in the 2026-2029 roadmap.